BACKGROUND: In sub-Saharan Africa, data for short-term risk of AIDS or death, which might inform decisions about when to start antiretroviral therapy (ART), are scarce. Our aim was to investigate these risks in patients who had no access to ART or who were given zidovudine alone. METHODS: 6-month risks (%) of death, AIDS, and combined risk of AIDS and death (AIDS/death) were calculated according to CD4-cell count category of less than 200 cells per microL, 200-350 cells per microL, or greater than 350 cells per microL, stratified by WHO clinical stages 1 and 2 combined, 3, or 4 in untreated patients (n=1399) seeking care in tertiary public-sector HIV clinics before widespread availability of ART in Cape Town, South Africa. FINDINGS: Risk of...
Background: Immediate initiation of antiretroviral therapy (ART) regardless of CD4 cell count reduce...
OBJECTIVES: To determine rates, risk factors and causes of death among patients accessing a communit...
Background: South Africa has undergone multiple expansions in antiretroviral therapy (ART) eligibili...
Background: Immediate initiation of antiretroviral therapy (ART) regardless of CD4 cell count reduce...
Abstract Background The risk of HIV-1 related mortality is strongly related to CD4 count. Guidance o...
BACKGROUND: High early mortality in patients with HIV-1 starting antiretroviral therapy (ART) in sub...
BACKGROUND: Immediate initiation of antiretroviral therapy (ART) regardless of CD4 cell count reduce...
Background: Immediate initiation of antiretroviral therapy (ART) regardless of CD4 cell count reduce...
BACKGROUND: High early mortality in patients with HIV-1 starting antiretroviral therapy (ART) in sub...
BACKGROUND: Immediate initiation of antiretroviral therapy (ART) regardless of CD4 cell count reduce...
OBJECTIVE: To determine the relationship between mortality risk and the CD4 cell response to antiret...
BACKGROUND High early mortality in patients with HIV-1 starting antiretroviral therapy (ART) in s...
Background: Immediate initiation of antiretroviral therapy (ART) regardless of CD4 cell count reduce...
Background: Immediate initiation of antiretroviral therapy (ART) regardless of CD4 cell count reduce...
Background: Immediate initiation of antiretroviral therapy (ART) regardless of CD4 cell count reduce...
Background: Immediate initiation of antiretroviral therapy (ART) regardless of CD4 cell count reduce...
OBJECTIVES: To determine rates, risk factors and causes of death among patients accessing a communit...
Background: South Africa has undergone multiple expansions in antiretroviral therapy (ART) eligibili...
Background: Immediate initiation of antiretroviral therapy (ART) regardless of CD4 cell count reduce...
Abstract Background The risk of HIV-1 related mortality is strongly related to CD4 count. Guidance o...
BACKGROUND: High early mortality in patients with HIV-1 starting antiretroviral therapy (ART) in sub...
BACKGROUND: Immediate initiation of antiretroviral therapy (ART) regardless of CD4 cell count reduce...
Background: Immediate initiation of antiretroviral therapy (ART) regardless of CD4 cell count reduce...
BACKGROUND: High early mortality in patients with HIV-1 starting antiretroviral therapy (ART) in sub...
BACKGROUND: Immediate initiation of antiretroviral therapy (ART) regardless of CD4 cell count reduce...
OBJECTIVE: To determine the relationship between mortality risk and the CD4 cell response to antiret...
BACKGROUND High early mortality in patients with HIV-1 starting antiretroviral therapy (ART) in s...
Background: Immediate initiation of antiretroviral therapy (ART) regardless of CD4 cell count reduce...
Background: Immediate initiation of antiretroviral therapy (ART) regardless of CD4 cell count reduce...
Background: Immediate initiation of antiretroviral therapy (ART) regardless of CD4 cell count reduce...
Background: Immediate initiation of antiretroviral therapy (ART) regardless of CD4 cell count reduce...
OBJECTIVES: To determine rates, risk factors and causes of death among patients accessing a communit...
Background: South Africa has undergone multiple expansions in antiretroviral therapy (ART) eligibili...